Home
ICON Views
Emerging Markets
Investigators
Contact
SERVICES
THERAPEUTICS
TECHNOLOGY
INVESTORS
NEWS & EVENTS
CAREERS
Preclinical/Phase I
ICON Development Solutions provides strategy and management in support of non-clinical drug development for all Phases.
Preclinical
Chemistry, Manufacturing & Control Consultancy
Regulatory Affairs
Bioanalytical
PK TK PK-PD Data Analysis
Phase I
Clinical Pharmacology Units
Expertise
Services
Regulatory Affairs
PK/PD Modeling and Simulation
Data Analysis
Bioanalytical
Clinical Pathology
Medical Writing
Quality Control/Assurance
Publishing
Pharmacodynamic Models
Biomarkers
Volunteer Recruitment
ICON plc - Clinical Research Organisation (CRO) for Drug Development »
Services »
Preclinical / Phase I »
Services »
Publishing
PRECLINICAL / PHASE I
PHASE II-IIIB
LATE PHASE
LABORATORIES
IMAGING
RESOURCING
Publishing
ICON offers preparation of electronic reports and regulatory submissions using industry-recognised tools such as Documentum, Core Dossier and ISI Toolbox.
Related News
ICON Strengthens Global Scientific Council with the Appointments of Professor Brendan Buckley and Dr. Nicholas Alp »
ICON Development Solutions Appoints Dr. Daniel Tang as General Manager Asia Pacific »
ICON PLC and Empire Genomics Partner for the Delivery of Personalised Medicine Services »
ICON Selected by the Biomarkers Consortium of the FNIH »
More news »
